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Pilot study, in a rental retirement village, of an “AdherenceCheck” on the management 1 
of medicines by the older-aged 2 
Introduction 3 
Medicines management, especially adherence, by the older-aged (those aged ≥ 65 years), is 4 
important as non-adherence is a common cause of hospital admissions, progression of disease 5 
and death [1].  Previously, we have shown that the older-aged living in a low socioeconomic, 6 
rental, retirement village have a low adherence to medicines and a poor understanding of 7 
their illnesses [2], and that this is ongoing [3].  This suggests that there is a need for extra 8 
assistance and resources for the older-aged, living in rental retirement villages, to manage 9 
their medicines. 10 
In Australia, one possible scheme performed by pharmacists that may be useful, as extra 11 
assistance for the older-aged, is the MedsCheck [4].  The MedsCheck is limited to those that 12 
are taking five medicines or more, and is performed by a pharmacist, accredited to do so [4].  13 
It is an in-pharmacy interview and involves detailing all prescription, non-prescription and 14 
complementary medications and identifying any allergies and any chronic conditions [4].  15 
The pharmacist then assesses medication adherence, assesses education needs to support 16 
improved understanding and use of medicines, provides education and guidance on correct 17 
use of medication/monitoring devices, and discusses management of chronic condition/s [4].  18 
After assessing the management of medicines, the pharmacist develops an Action Plan with 19 
the subject in an attempt to resolve any medication-related issues [4].  It is not mandatory for 20 
the pharmacist to make follow-ups or provide details of the Action plan to other health 21 
professionals [4].  The MedsCheck is aimed at people living in a community setting, and is 22 
available annually [4].  To our knowledge, which included a search of PubMed and Google 23 
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Scholar for ‘MedsCheck’, there are no studies testing whether an Australian MedsCheck 24 
improves the management of medicines by the recipient.   25 
 26 
There are also some limitations to the MedsCheck.  Firstly, the MedsCheck is performed in a 27 
designated consultation area at the pharmacy, but not all subjects visit the pharmacy.  For 28 
instance, 40-48% of the older-aged participants, from the rental retirement villages in our 29 
previous studies, were having their medicines delivered [2,3], and consequently were not 30 
visiting a community pharmacy.  Secondly, to be eligible for a MedsCheck, subjects must be 31 
taking five or more medicines, and this may exclude some subjects who do not manage their 32 
medicines well.  Thus, although it has been shown that polypharmacy may increase the poor 33 
management of medicines in the older-aged living in the community [5,6], this is not always 34 
the case [7], and there is no evidence that poor management is confined to those with 35 
polypharmacy. 36 
 37 
Aim of study 38 
The aim of our study was to determine the effect of an AdherenceCheck undertaken in the 39 
home of the older-aged living independently in a rental retirement village, had on the ongoing 40 
management of medicines by this group.   41 
 42 
Ethical approval 43 
Ethical approval for this research was obtained from Queensland University of Technology 44 
Human Ethics Committee (Approval Number: 1000001025).   45 
 46 
 47 
 48 
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Methods 49 
None of the participants that we have interviewed previously, in the rental retirement village, 50 
had reported having a MedsCheck, and thus this may be an appropriate intervention, to assist 51 
the older-aged manage their medicines.  However, as it was impractical to use a MedsCheck 52 
in a retirement village, we decided to modify the MedsCheck, and to use as our intervention, 53 
an “AdherenceCheck”.  The AdherenceCheck was designed to be similar to the MedsCheck 54 
with the major exception that it was performed in the homes of the older-aged living at a 55 
retirement village, rather than at the pharmacy.  For consistency, the AdherenceChecks were 56 
all performed by the same pharmacist.  Our AdherenceCheck, unlike a MedsCheck, was 57 
delivered to all of the older-aged, regardless of the number of medicines they took.  Thus, all 58 
subjects in the village (nonadherent and adherent), who took less than five medicines, could 59 
be included in our study. 60 
 61 
We secured permission to undertake the study from the manager of the low socioeconomic, 62 
rental retirement village. The village has 50 occupied units, and flyers were distributed to the 63 
resident’s homes, briefly telling them about the nature of the study, and that we would be 64 
door knocking on set dates to ask them to participate.  For those residents who consented to 65 
participate, semi-structured interviews were conducted by two researchers in the homes of the 66 
participants. The interviews enquired about their age, and information about their medical 67 
conditions and medicines, without their medicines being present.  Then, participants were 68 
requested to show the researchers their medicine cabinet/store, and individual medicines were 69 
discussed in more detail.   70 
 71 
As part of the semi-structured interview, we asked the participants the following questions, 72 
based on the Morisky scale [8]: Do you ever forget to take your medicines? Are you careless 73 
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at times about taking your medicine?  When you feel better do you sometimes stop taking 74 
your medicine?  Sometimes if you feel worse when you take the medicine, do you stop taking 75 
it? From these questions we estimated whether the participants were adherent at the ≥ 80% 76 
level, which we describe as adherent, or were < 80% adherent (nonadherent).   77 
 78 
Perception of future adherence was determined as described in our previous studies [2,3].  79 
Thus, after the interviews were complete, each researcher independently wrote five sentences 80 
about each participant in this study; describing his/her ability to manage their medicines, and 81 
classifying them into one of four adherence categories.  The categories are given in the Table, 82 
under perception of adherence, and range from unlikely to have problems with adherence in 83 
next 6-12 months to being at ongoing risk of nonadherence.  The five sentences and 84 
categorization formed the basis for a discussion between the researchers of their perception of 85 
the ongoing adherence to medicines of the participants and when consensus was reached, the 86 
participants were classified.  87 
 88 
To determine the participant’s knowledge of their illness, they were asked on two occasions, 89 
whether they knew for which illnesses (medical conditions) they were taking medicines; 90 
firstly, in the part of the interview without the medicine being present, and secondly, in the 91 
part of the interview where we look at, and discuss each medication.  For each participant, for 92 
each medical condition, their knowledge was classified as ‘good’ (which was to know 93 
precisely which illness/es they had), ‘some’ (which was having some knowledge but it was 94 
not precise), or ‘no’ (which was having no knowledge of their illness/es). 95 
 96 
Dr Vincent Chan is a consultant pharmacist who is accredited and experienced in delivering 97 
MedsChecks in the community pharmacy, and Residential Medication Management Reviews 98 
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in homes.  After the interviews with the participants, Dr Chan performed the 99 
“AdherenceCheck” for all participants.  This check, like a MedsCheck (4), consisted of:  100 
1.  Assessing medication adherence (which was done as described above). 101 
2. Assessing education needs including the provision of written information to support 102 
improved understanding and use of medicines. 103 
3.  Providing education and guidance on correct use of medication/monitoring devices. 104 
4. Attempting to resolve any medication-related issues that have been identified from the 105 
information.  106 
5. Developing a brief written action plan including agreed participant goals and actions, and 107 
any agreed follow-up with participant’s GP, and provide the participant with a copy of the 108 
Action plan. 109 
 110 
We added our photos to the Action plans, and delivered and discussed them with the 111 
participants, within 2 weeks of the interviews.  Six months later we re-interviewed the 112 
participants about their management of medicines, using the same questionnaire, plus an 113 
extra section on the Action plan. 114 
 115 
Comparisons, before and after the AdherenceCheck, for age, number of medicines and 116 
knowledge of illness were made by Students paired t-test.  Other comparisons were made by 117 
determining the Odds ratio with 95% confidence levels (OR with 95% CI) using the MedCalc 118 
statistical calculator: https://www.medcalc.org/calc/odds_ratio.php.  For all statistics used, a p 119 
value of < 0.05 was considered significant.   120 
 121 
 122 
 123 
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Results 124 
Start of the study: Forty individuals from the 50 units responded to our door knock, and at the 125 
start of the study (the Initial group), 23 agreed to participate (11 females), and the participants 126 
had an average age of 75 ± 2 years.  There was no difference between the researchers in 127 
categorising the participants to levels of adherence, and perception was that 48% were 128 
adherent at the time of the study and unlikely to have problems in the next 6-12 months 129 
(Table 1).  Table 1 also provides information on the number of prescription and non-130 
prescription medicines used, medication collection, use of medication organizers, and the 131 
most commonly prescribed medicines.  In the initial group, less than 60% of the participants 132 
had a good knowledge of their illnesses (Figure 1).   133 
Only 15 of the original participants completed the study.  Thus, in the intervening 6 months, 134 
8 participants were lost from the study; 4 declined to continue, 3 left the village, and 1 had 135 
died.  Despite the loss of 8 participants, there was no difference between the characteristics of 136 
the initial group and the 15 participants (who went on to complete the study), at the start of 137 
the study (the Pre-AdherenceCheck group): Table 1 and Figure 1. 138 
Post-AdherenceCheck: The data pre- and post-AdherenceCheck is given in Table 1.  The 139 
AdherenceCheck did not significantly change the percentage of participants who were 140 
adherence to medicines (Adherent vs non-adherent, pre- vs post-AdherenceCheck OR = 2.29, 141 
CI 0.52 to 10.01, P = 0.276), or any other aspects of the management of medicines given in 142 
Table 1.  Of the 5 participants who were nonadherent (Class D) pre-AdherenceCheck, 3 143 
remained so post-AdherenceCheck.  In contrast, 4 adherent participants pre-AdherenceCheck 144 
(Class A) were nonadherent (Class D) post-AdherenceCheck. 145 
There was a reduced use of cardiovascular/anti-thrombotic medicines, pre- to post-146 
AdherenceCheck, 93% to 67%, but this did not reach significance (OR = 0.14, CI 0.01 to 1.4, 147 
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P = 0.10).  Pre- to post-AdherenceCheck, there was a reduction in the percentage of 148 
participants with a good knowledge of their illnesses, and thus a corresponding significant 149 
increase in the percentage with no knowledge of their illnesses (Figure 1).   150 
After the six months, 11 of the 15 participants remembered receiving an “Action Plan”. Of 151 
these 11, 7 considered that the action plan helped them manage their medicines, and 9 would 152 
advise friends or relatives to have an AdherenceCheck.  Three followed-up on the Action 153 
Plan by discussing medications with their general practioner.  Of the 5 pre-AdherenceCheck 154 
participants who were nonadherent (class D at start), only two reported using their Action 155 
Plan, and this was associated with improved adherence post-AdherenceCheck.  Of the 7 pre-156 
AdherenceCheck participants who were fully adherent (class A at start), only three reported 157 
using their Action Plan and one of these was adherent and two were nonadherent post-158 
AdherenceCheck. 159 
Discussion 160 
Despite, the website of the 6th Community Pharmacy Agreement, between the community 161 
pharmacists and Australian government, stating that “Medication Adherence Programmes 162 
improve medication compliance through the provision of community pharmacy services” [4], 163 
we could find no published evidence that one of the programs offered in Australia, the 164 
MedsCheck programme, had been evaluated to determine whether it improved the 165 
management of medicines by the recipients (discussed in Introduction).  The MedsCheck in 166 
Australia is based on the MedsCheck Ontario, Canada, which has been operating since 2007, 167 
and is a 20-30 minute interview with the pharmacist, which can be repeated annually [9].  To 168 
qualify for the Ontario MedsCheck, residents must be taking at least 3 prescription 169 
medications for chronic conditions. The interview by the pharmacist at the pharmacy 170 
considers lifestyle information, the need for the MedsCheck Service (which includes non-171 
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adherence), current medication list, therapeutic issues identified, and plans for follow-up with 172 
a healthcare provider [9].  Although there is evidence that the service is widely used [10,11], 173 
to our knowledge, there is no published evidence that the Ontario MedsCheck improves the 174 
management of medicines by the recipients.  A similar program to the Ontario/Australian 175 
MedsCheck is performed as the Medicine Use Review (MUR) in the UK [12].  This MUR 176 
service takes an average of 10 minutes in the pharmacy [13], and has not been evaluated by 177 
peer-review, to determine whether it alters the management of medicines by the recipient.  178 
Thus, our review of the literature (which included searches of PubMed and Google Scholar) 179 
suggested that there were no studies that tested whether brief/single interventions by a 180 
pharmacist in-pharmacy, such as MedsCheck or MURs, improve the management of 181 
medicines by recipients.  Thus, our study may have been the first to test whether a brief one-182 
time adherence check improves the management of medicines. 183 
There were some practical reasons for not using the MedsCheck as our intervention 184 
(discussed in Methods), but the AdherenceCheck intervention was closely modelled on the 185 
MedsCheck.  Our pilot study shows that the AdherenceCheck may not improve the 186 
management of medicines in the older-aged living in a rental retirement village.  Thus, an 187 
AdherenceCheck may not be an appropriate intervention to use in this setting to improve the 188 
adherence to medicines.  Although this does not prove that MedsChecks, or brief MURs, are 189 
ineffective, it does suggest that these programs need assessment to determine whether they 190 
are effective, especially as there is no existing evidence that they are effective. 191 
Rather than improvement in the management of medicines over the six months of the 192 
AdherenceCheck, we showed that there was a loss of knowledge of illnesses by the older-193 
aged, and a non-significant tendency towards reduced adherence and more nonadherence.  194 
These differences may be associated with their increasing age of the participants by 6 195 
months.  In our previous study, we reported the management of medicines by the older-aged 196 
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living independently in a rental retirement village was ongoing and similarly poor over 3 197 
years [3].  However, in this previous study, the cohort changed on each occasion, and the 198 
average age was 75 years on all 3 occasions [3].  This contrasts with the present study, where 199 
the same cohort was followed for 6 months, their age increased by 6 months, and this was 200 
associated with deterioration in the management of medicines.   201 
There are several alternate explanations to aging, as to why the AdherenceCheck led to the 202 
deterioration in the management of medicines by the older-aged living in the retirement 203 
village. Firstly, and this seems unlikely, is that the AdherenceCheck, rather than age, led to 204 
the deterioration. This could only be discounted by performing a study, which compared a 205 
control group that aged but did not have an AdherenceCheck with a group that aged, and had 206 
an AdherenceCheck.  Secondly, as this was a pilot study with a small number of participants, 207 
it was not powered to determine whether an AdherenceCheck could improve the management 208 
of medicines, and this may explain the negative result.  To conclusively determine whether an 209 
AdherenceCheck had an effect on the management of medicines, a much larger study with 210 
more power would be necessary.  Thirdly, as nearly half of participants were adherent pre-211 
AdherenceCheck, it may not have been possible to improve the adherence of this group.  To 212 
test this, nonadherent participants only could be targeted with the AdherenceCheck in a 213 
study.  However, it should be noted that some of the participants who were adherent pre-214 
AdherenceCheck were not so 6 months later, and thus the adherent group may also need 215 
support to maintain good management of medicines. 216 
As the AdherenceCheck, as a whole, did not improve the adherence to medicines in this 217 
population, the Action Plans, given to the older-aged after the AdherenceCheck and not 218 
revisited over 6 months, are possibly ineffective.  Reasons for this are that some of the 219 
participants forgot about them, and others did not actively engage with their Action Plan.  It 220 
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would be of interest to determine whether Action Plans become more effective, if they are 221 
reinforced on a regular basis. 222 
The finding that a brief/single intervention by a pharmacist, the AdherenceCheck, may not 223 
improve the management of medicines in the older-aged, living in rental retirement villages, 224 
is consistent with other studies of brief/single interventions by pharmacists.  Thus, in subjects 225 
with hypertension, it has been shown that interventions that involved a single meeting with 226 
the pharmacist [USA; 14,15, Hong Kong; 16] or involving a brief interview with the subjects 227 
when collecting prescriptions for the pharmacy [Canada; 17] did not improve the adherence 228 
to antihypertensive medications.  Thus, the finding that brief/single interventions by a 229 
pharmacist is not enough to improve the management of medicines, may not be limited to the 230 
older-aged. 231 
In contrast there is evidence that more substantial interventions by pharmacists do improve 232 
the management of medicines by recipients.  Thus, in New Zealand, the MUR is more 233 
substantial than the one undertaken in the UK, and involves meeting with the subject to help 234 
then find out more about the medicines they are taking, identify any problems them may be 235 
having with their medicines, and improving the effectiveness of the medicines being taken 236 
[18].  The New Zealand MUR takes an average of 57 minutes [19], can involve repeat 237 
visits/consultations up to 4, and has been shown to increase the subjects’ knowledge, 238 
perception of, and adherence to medicines with each visit [20].  Similarly, more substantial 239 
interventions by pharmacists have been shown to improve adherence to medicines for 240 
hypertension [USA; 21, Australia; 22, Denmark; 23].  This suggests, that to be effective in 241 
improving the management of medicines, an intervention by a pharmacist needs to be 242 
substantial. 243 
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The major limitation of our study, with regard to the evaluation of the AdherenceCheck, is 244 
that the sample size is small, and the study is restricted to the older-aged living in a rental 245 
retirement village.  The small sample size may have prevented us from finding changes in the 246 
management of medicines with the AdherenceCheck.  Thus, further studies of the 247 
MedsCheck or AdherenceCheck in larger populations are indicated. As we have consistently 248 
shown that the older-aged living in this rental retirement village had poor management of 249 
medicines [2,3], this was an important population to study.  It would be of interest to 250 
determine the effects of an AdherenceCheck in a larger rental retirement village or in a 251 
leasehold rental village, as we have also demonstrated that the older-aged living in a 252 
leasehold rental village have poor management of medicines [24].  Our study also did not 253 
preclude AdherenceCheck and/or MedsCheck being effective in improving the management 254 
of medicines in other populations, and this also needs to be tested. 255 
Conclusions 256 
A pilot study has shown that AdherenceCheck did not improve the management of medicines 257 
by the older-aged living in a rental retirement village.  As there are no peer-reviewed 258 
publications as to whether the commonly used MedsCheck, which the AdherenceCheck was 259 
based on, improve the management of medicines, it is suggested that these MedsCheck 260 
should also be formally evaluated. 261 
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Table 1: Effect of “AdherenceCheck” on the management of medicines in a rental 332 
retirement village 333 
 334 
 Initial 
group 
(n =23)
Pre-
AdherenceCheck
(n = 15)
Post-
AdherenceCheck
(n = 15)
Age 75 ± 2 75 ±  3 76 ±  3*
Perception of adherence    
A: Adherent and unlikely to have 
problems with adherence in next 6-12 
months 
48% 60% 47% 
B: Adherent but at risk of 
nonadherence in next 6 months 
9% 0% 0% 
C: Adherent but at immediate risk of 
nonadherence 
4% 7% 6% 
D: Nonadherent and at ongoing risk of 
nonadherence 
39% 33% 47% 
Number of medicines  
Prescription medicines/person 6.7 ± 0.7 7.3 ± 1.0 8.3 ± 1.2
Non-prescription medicines/person 1.4 ± 0.4 1.9 ± 0.6 1.9 ± 0.8
Medication collection  
Self 43% 27% 27% 
Friend/relative 13% 7% 7% 
Pharmacy delivers 47% 66% 66% 
Medication organiser  
No 70% 67% 73% 
Packed by pharmacy/carer 26% 26% 20% 
Self-packed 4% 7% 7% 
Commonest medicines used  
Cardiovascular/anti-thrombotic 87% 93% 67% 
Gastrointestinal  48% 60% 40% 
Analgesic  43% 47% 47% 
Respiratory  30% 27% 27% 
Psychotropic 25% 28% 27% 
Neurologic 23% 25% 10% 
Endocrine 13% 11% 13% 
 335 
Values are means ± SEM. 336 
* p ≤ 0.05, by Student’s t-test with pre-AdherenceCheck value 337 
 338 
 339 
 340 
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Figure 1. Knowledge of illnesses by the older-aged living in a rental retirement village   341 
Values are means ± SEM. 342 
* p ≤ 0.05, by Student’s t-test with pre-AdherenceCheck value 343 
 344 
